�A nationally recognized healthcare policy technical at UC San Diego School of Medicine is available to discuss campaign issues related to to health care plans/promises.
Richard Kronick, Ph.D., professor, Department of Family and Preventive Medicine and adjunct professor, Department of Political Science, is available to speak on many healthcare-related issues such as strategies for masking the uninsured, options for controlling cost growth, and Medicare and Medicaid policy.
Dr. Kronick served as a Senior Health Care Policy Advisor in the Clinton Administration, where he contributed to the development of President Clinton's proposal for health care reform. He also served as Director of Policy and Reimbursement in the Massachusetts Department of Public Welfare and the Assistant Director in the Massachusetts Office of Health Policy. He is also knotty in the Healthcare Executive Leadership Program (HELP), a program intentional by UC San Diego in the mid 90s to augment the experience of health care executives from a potpourri of backgrounds.
University of California, San Diego
University Communications, 0938 9500 Gilman Dr.
LaJolla, CA 92093
United States
http://www.ucsd.edu/portal/site/ucsd
More info
Sunday, 24 August 2008
Wednesday, 6 August 2008
New Guidelines For Treating Rheumatoid Arthritis
�Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the handling of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (UAB).
Lead author Kenneth Saag, M.D., M.Sc., a professor in the UAB Division of Clinical Immunology and Rheumatology, said the new guidelines update strategies for treating RA with the goal of preventing joint wrong and disability.
The new recommendations do non strive to replace individualized medical decisions, Saag aforementioned. Instead, they are meant to
Lead author Kenneth Saag, M.D., M.Sc., a professor in the UAB Division of Clinical Immunology and Rheumatology, said the new guidelines update strategies for treating RA with the goal of preventing joint wrong and disability.
The new recommendations do non strive to replace individualized medical decisions, Saag aforementioned. Instead, they are meant to
Subscribe to:
Posts (Atom)